skip to main content

Type 2 diabetes with ASCVD — USMLE Step 3 MCQ

Instant feedback + full explanation. One question, done properly.

ModerateInternal Medicine (chronic management)Type 2 diabetes with ASCVDUSMLE Step 3

A 64-year-old man with type 2 diabetes returns for follow-up. A1c is 8.1% despite metformin. He has prior myocardial infarction and estimated GFR of 72 mL/min/1.73 m2. BMI is 31 kg/m2. He has no history of pancreatitis. Which of the following is the most appropriate next step in management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: AAdd a GLP-1 receptor agonist with cardiovascular benefit

In type 2 diabetes with established ASCVD, a GLP-1 receptor agonist or SGLT2 inhibitor with cardiovascular benefit is preferred.

Reference: ADA Standards of Care in Diabetes 2026